ASHP gives input on Declaration of Helsinki guidelines
ASHP is urging the World Medical Association to use pharmacists and other allied healthcare professionals more frequently as research investigators.
ASHP is urging the World Medical Association (WMA) to use pharmacists and other allied healthcare professionals more frequently as research investigators. In an Aug. 20 letter, ASHP executive VP/CEO Henri R. Manasse Jr. urged WMA to "reinforce that all health professionals" be involved in the research process and "adhere to the Declaration of Helsinki." The document outlines ethical principles for medical research involving human subjects. ASHP's comments also encouraged WMA to emphasize health literacy and risk communication as essential elements of informed consent and highlighted the importance of a full disclosure of potential conflicts of interest.
Click here to see more articles from Drug Topics Daily News.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
